Indibulin

CAS : 204205-90-3

Ref. 3D-EIA20590

Informations sur le produit

• Nom: Indibulin
• Synonymes: 2-(1-(4-Chlorophenylmethyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide, 2-[1-(4-chlorobenzyl)-1H-indol-3-yl]-2-oxo-N-(pyridin-4-yl)acetamide

Description

Indibulin is a potent antitumor agent that inhibits the assembly of tubulin. It has been shown to have significant cytotoxicity against prostate cancer cells and potent antiangiogenic properties. Indibulin has been shown to inhibit the production of epidermal growth factor, which is involved in tumor angiogenesis, by binding to the epidermal growth factor receptor. Indibulin also binds to excipients, such as mannitol and lactose, forming a granulate for intravenous injection. This drug has been shown to have pharmacokinetic properties in vitro and in vivo studies.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 389.83 g/mol
• Formule: C₂₂H₁₆ClN₃O₂
• Degré de pureté: Min. 95%